Urologist Newcastle upon Tyne
- 0191 233 6161
- Freeman Rd, High Heaton, Newcastle upon Tyne NE7 7DN, UK
Rhona McMenemin Consultant Clinical Oncologist Newcastle delivers expert cancer care at the Freeman Hospital’s Northern Centre for Cancer Care. She specializes in both lung and urological cancers. With decades of experience, Dr McMenemin brings deep knowledge, dedication, and compassion to every patient she treats.
Dr Rhona McMenemin qualified from the prestigious Glasgow University in 1988. She quickly distinguished herself in the field of oncology. Through her early training and dedication, she developed a strong foundation in patient-centred cancer care. Her commitment to excellence led her to Newcastle, where she became a Consultant Clinical Oncologist in 2001.
Rhona McMenemin Consultant Clinical Oncologist Newcastle also serves as the supra network lead for testicular cancer. In this role, she ensures consistent, high-quality care across multiple centres. Her leadership helps drive forward treatment protocols and clinical outcomes. Moreover, she works closely with fellow specialists to align strategies for better patient results.
Dr McMenemin’s passion for oncology extends into education. As a Royal College of Radiologists (RCR) examiner for the final FRCR in Clinical Oncology, she helps shape future oncologists. Her detailed understanding of clinical training standards benefits both students and the medical community. Additionally, she leads Student Selected Options in Clinical Oncology, guiding medical students with hands-on learning opportunities.
In addition to clinical work, Rhona McMenemin Consultant Clinical Oncologist Newcastle plays a key role in advancing oncology research. She serves as Vice Chair of the Radiotherapy Clinical Trials Group. This position allows her to contribute to cutting-edge studies that influence cancer treatment nationwide. Her work ensures that patients benefit from evidence-based innovations.
Throughout her career, Dr McMenemin has balanced leadership, education, and clinical expertise with compassion. She remains committed to delivering optimal care, supporting research, and mentoring the next generation of oncologists. Her ongoing contributions make a significant difference in the lives of patients and their families.
